113 related articles for article (PubMed ID: 29969588)
21. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
Teh MT; Parkinson EK; Thurlow JK; Liu F; Fortune F; Wan H
J Oral Pathol Med; 2011 Jan; 40(1):67-76. PubMed ID: 20923451
[TBL] [Abstract][Full Text] [Related]
22. Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. clues from an in vitro invasion model.
Berndt A; Hyckel P; Könneker A; Katenkamp D; Kosmehl H
Invasion Metastasis; 1997; 17(5):251-8. PubMed ID: 9876219
[TBL] [Abstract][Full Text] [Related]
23. In vivo ultrastructural localization of the desmoglein 3 adhesive interface to the desmosome mid-line.
Shimizu A; Ishiko A; Ota T; Saito H; Oka H; Tsunoda K; Amagai M; Nishikawa T
J Invest Dermatol; 2005 May; 124(5):984-9. PubMed ID: 15854040
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling.
Lu CC; Yang JS; Chiang JH; Hour MJ; Amagaya S; Lu KW; Lin JP; Tang NY; Lee TH; Chung JG
Anticancer Res; 2012 Jul; 32(7):2895-903. PubMed ID: 22753753
[TBL] [Abstract][Full Text] [Related]
25. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.
Brown L; Waseem A; Cruz IN; Szary J; Gunic E; Mannan T; Unadkat M; Yang M; Valderrama F; O'Toole EA; Wan H
Oncogene; 2014 May; 33(18):2363-74. PubMed ID: 23752190
[TBL] [Abstract][Full Text] [Related]
26. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells.
Aoyama Y; Kitajima Y
J Invest Dermatol; 1999 Jan; 112(1):67-71. PubMed ID: 9886266
[TBL] [Abstract][Full Text] [Related]
27. Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells.
Thomas GJ; Lewis MP; Whawell SA; Russell A; Sheppard D; Hart IR; Speight PM; Marshall JF
J Invest Dermatol; 2001 Jul; 117(1):67-73. PubMed ID: 11442751
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
29. Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.
Teixeira LN; de Castro Raucci LM; Alonso GC; Coletta RD; Rosa AL; de Oliveira PT
Tumour Biol; 2016 Sep; 37(9):12371-12385. PubMed ID: 27312487
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
[TBL] [Abstract][Full Text] [Related]
31. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
32. Endostatin induces proliferation of oral carcinoma cells but its effect on invasion is modified by the tumor microenvironment.
Alahuhta I; Aikio M; Väyrynen O; Nurmenniemi S; Suojanen J; Teppo S; Pihlajaniemi T; Heljasvaara R; Salo T; Nyberg P
Exp Cell Res; 2015 Aug; 336(1):130-40. PubMed ID: 26112215
[TBL] [Abstract][Full Text] [Related]
33. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
Hashimoto T; Amagai M; Garrod DR; Nishikawa T
Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
[TBL] [Abstract][Full Text] [Related]
34. Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are associated with aggressive clinicopathological features of oral squamous cell carcinoma.
Xin Z; Yamaguchi A; Sakamoto K
Virchows Arch; 2014 Jul; 465(1):35-47. PubMed ID: 24849508
[TBL] [Abstract][Full Text] [Related]
35. Cetuximab has an inhibitory effect on cell motility in SCC-4 oral squamous cell carcinoma cell line.
Furtado LM; Da Silveira IC; Carneiro ACDM; Zehuri MMON; Carboni SSCM; Tavares-Murta BM; Crema VO
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):13-17. PubMed ID: 28980916
[TBL] [Abstract][Full Text] [Related]
36. The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.
Melchiori A; Mortarini R; Carlone S; Marchisio PC; Anichini A; Noonan DM; Albini A
Exp Cell Res; 1995 Jul; 219(1):233-42. PubMed ID: 7628538
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration.
Yamada KM; Kennedy DW; Yamada SS; Gralnick H; Chen WT; Akiyama SK
Cancer Res; 1990 Aug; 50(15):4485-96. PubMed ID: 2369727
[TBL] [Abstract][Full Text] [Related]
38. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
[TBL] [Abstract][Full Text] [Related]
39. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.
Koga H; Tsuruta D; Ohyama B; Ishii N; Hamada T; Ohata C; Furumura M; Hashimoto T
Expert Opin Ther Targets; 2013 Mar; 17(3):293-306. PubMed ID: 23294403
[TBL] [Abstract][Full Text] [Related]
40. Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3.
Feng Y; Qian R; Cui D; Luan J; Xu M; Wang L; Li R; Wu X; Chang C
J Cancer Res Clin Oncol; 2024 Jun; 150(6):312. PubMed ID: 38900156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
